Zobrazeno 1 - 10
of 53
pro vyhledávání: '"N. Davarpanah"'
Autor:
Lisa M. Cordes, Nicole N. Davarpanah, Lauren B. Reoma, Billel Gasmi, Martha Quezado, Omar I. Khan, Avindra Nath, Andrea B. Apolo
Publikováno v:
Clinical Case Reports, Vol 8, Iss 1, Pp 24-32 (2020)
Abstract We report a case of nivolumab‐induced delayed‐onset aseptic meningitis and a case of limbic encephalitis and peripheral nerve palsy with toxicity relapse 6 months after initial presentation. The atypical presentations contribute to our k
Externí odkaz:
https://doaj.org/article/0ffa80179e93400d9777ea84b56ff176
Autor:
T. Powles, Z. June Assaf, S. Mariathasan, M. Hussain, S. Oudard, P. Albers, D. Castellano, H. Nishiyama, S. Daneshmand, P. Grivas, S. Sharma, H. Sethi, A. Aleshin, V. Degaonkar, Y. Shi, N. Davarpanah, C.A. Carter, J. Bellmunt, J.E. Gschwend
Publikováno v:
European Urology Open Science. 45:S216-S217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef381f5d58eecbb68c8f962715d00f93
https://doi.org/10.1016/s2666-1683(22)02565-4
https://doi.org/10.1016/s2666-1683(22)02565-4
Autor:
Rosa Nadal, Piyush K. Agarwal, Sumanta K. Pal, Biren Saraiya, Howard L. Parnes, Donald P. Bottaro, Daniel Girardi, Vladimir Valera, Mohammad Hadi Bagheri, Lisa Ley, Scot Anthony Niglio, Olena Sierra Ortiz, Seth M. Steinberg, Yangmin M. Ning, Primo N. Lara, William D. Figg, Paul Monk, Heather J. Chalfin, Mark N. Stein, Howard Streicher, Carlos Diaz, Marissa Mallek, Amir Mortazavi, Maria J. Merino, Jacqueline Cadena, Rene Costello, Min-Jung Lee, Jane B. Trepel, William L. Dahut, Nicole N. Davarpanah, James L. Gulley, Andrea B. Apolo, John J. Wright, Jennifer Jones, Lisa M. Cordes
Publikováno v:
Journal of Clinical Oncology
PURPOSE We assessed the safety and efficacy of cabozantinib and nivolumab (CaboNivo) and CaboNivo plus ipilimumab (CaboNivoIpi) in patients with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignances. PATIENTS AND METHODS Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57aa8802a4543aa052b3e2026f87d0a8
https://doi.org/10.1200/jco.20.01652
https://doi.org/10.1200/jco.20.01652
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrea B. Apolo, Nicole N. Davarpanah, Martha Quezado, Lisa M. Cordes, Lauren B. Reoma, Avindra Nath, Billel Gasmi, Omar I. Khan
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 1, Pp 24-32 (2020)
Clinical Case Reports, Vol 8, Iss 1, Pp 24-32 (2020)
We report a case of nivolumab‐induced delayed‐onset aseptic meningitis and a case of limbic encephalitis and peripheral nerve palsy with toxicity relapse 6 months after initial presentation. The atypical presentations contribute to our knowledge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64cbf263dcc80688aaf0b43ed68544dc
http://europepmc.org/articles/PMC6982490
http://europepmc.org/articles/PMC6982490
Autor:
Jens Bedke, Stéphane Oudard, Sanjeev Mariathasan, Maha Hussain, Daniel M. Geynisman, Thomas Powles, Peter H. O'Donnell, Yi Shi, Daniel P. Petrylak, Cora N. Sternberg, Hiroyuki Nishiyama, Michiel S. van der Heijden, Jean H. Hoffman-Censits, Siamak Daneshmand, Daniel Castellano, Petros Grivas, Nicole N. Davarpanah, Jonathan E. Rosenberg, Alexandra Drakaki, Yousef Zakharia, Viraj Degaonkar, Arash Rezazadeh Kalebasty, Joaquim Bellmunt, Martin Majchrowicz, Jürgen E. Gschwend, Peter Albers
Publikováno v:
Lancet Oncol
Summary Background Despite standard curative-intent treatment with neoadjuvant cisplatin-based chemotherapy, followed by radical surgery in eligible patients, muscle-invasive urothelial carcinoma has a high recurrence rate and no level 1 evidence for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b9c0d126f214411f14fc8f4c5d70cb
https://europepmc.org/articles/PMC8495594/
https://europepmc.org/articles/PMC8495594/
Autor:
Viraj Degaonkar, Petros Grivas, Karim Chamie, Nicole N. Davarpanah, Alexandra Drakaki, Allan J. Pantuck, Preet K. Dhillon, Shivani K. Mhatre, Andy Surinach
Publikováno v:
Urologic oncology. 39(1)
Introduction There is no current standard of care for patients with high-risk muscle-invasive urothelial carcinoma (MIUC) after neoadjuvant chemotherapy and surgical resection or for those who cannot receive or decline cisplatin-based perioperative c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1007f8afe7a004088618872a32fe2b
https://pubmed.ncbi.nlm.nih.gov/32778476
https://pubmed.ncbi.nlm.nih.gov/32778476
Autor:
Tristan M. Sissung, Donald P. Bottaro, Kimaada Allette, John Wright, Rosa Nadal, Min-Jung Lee, Rene Costello, Molly M. Lee, Akira Yuno, Les R. Folio, Maria Merino, Yangmin M. Ning, Liza Lindenberg, Jeffrey Lin, Seth M. Steinberg, Sunmin Lee, Lisa M. Cordes, Dinuka M. De Silva, Arpita Roy, Piyush K. Agarwal, William D. Figg, Jane B. Trepel, Howard L. Parnes, Mark Raffeld, William L. Dahut, Sylvia V. Alarcon, Nancy A. Dawson, Nicole N. Davarpanah, James L. Gulley, Yusuke Tomita, Andrea B. Apolo, Liang Cao
Publikováno v:
The Lancet. Oncology. 21(8)
Summary Background Cabozantinib is a multikinase inhibitor of MET, VEGFR, AXL, and RET, which also has an effect on the tumour immune microenvironment by decreasing regulatory T cells and myeloid-derived suppressor cells. In this study, we examined t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfddce4bbbf7ca27a869e0d52173d8be
https://pubmed.ncbi.nlm.nih.gov/32645283
https://pubmed.ncbi.nlm.nih.gov/32645283
Autor:
Amanda Young, Halla Nimeiri, Russell Madison, Alexander D. Fine, Daniel Zollinger, Ole Gjoerup, Vasily N. Aushev, Hsin-Ta Wu, Alexey Aleshin, Nicole N. Davarpanah, Zoe Assaf, Sanjeev Mariathasan, Geoffrey R. Oxnard, Elise Renkonen, Thomas Powles, Priti Hegde
Publikováno v:
Journal of Clinical Oncology. 40:448-448
448 Background: There is compelling rationale that detection of MRD following curative therapy may identify patients at high risk of relapse requiring intensified adjuvant therapy. Combining MRD detection with CGP creates an opportunity to offer MRD-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7aaf7779e58c60bae8cb9637431f8a6
https://doi.org/10.1200/jco.2022.40.6_suppl.448
https://doi.org/10.1200/jco.2022.40.6_suppl.448
Autor:
Noah M. Hahn, Gary D. Steinberg, Kelly Lynn Stratton, Ryan P. Kopp, Alexander Sankin, Eila C. Skinner, Kamal S. Pohar, Benjamin Adam Gartrell, Song Pham, Deepali Rishipathak, Sanjeev Mariathasan, Nicole N. Davarpanah, Corey Carter, Brant Allen Inman
Publikováno v:
Journal of Clinical Oncology. 40:493-493
493 Background: Standard treatment (tx) for high-risk NMIBC is transurethral resection of bladder tumor (TURBT) followed by BCG induction and maintenance. However, ≈50% of pts experience recurrence and/or progression after tx and may be ineligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388ddc31dc5ce714a856663c9475d780
https://doi.org/10.1200/jco.2022.40.6_suppl.493
https://doi.org/10.1200/jco.2022.40.6_suppl.493